ACERTIS PHARMACEUTICALS
Dead / Abandoned — Abandoned — after publication (as of 10 Feb 2020)
What this means for you
This application is over — abandoned 10 Feb 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88453270
- Mark type
- Design + words
- Filed
- 30 May 2019
- Published for opposition
- 15 Oct 2019
- Abandoned
- 10 Feb 2020
- Attorney of record
- Megan M. New
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of endometrial hyperplasia and the management of exogenous obesity
Owner
- Acertis Pharmaceuticals, LLC, Langhorne, PA, US
- Acertis Pharmaceuticals, LLC, Langhorne, PA, US
Prosecution history
- 10 Feb 2020 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 10 Feb 2020 — ABANDONMENT - AFTER PUBLICATION
- 05 Feb 2020 — TEAS EXPRESS ABANDONMENT RECEIVED
- 08 Nov 2019 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 15 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2019 — PUBLISHED FOR OPPOSITION
- 25 Sept 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Sept 2019 — ASSIGNED TO LIE
- 05 Sept 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Sept 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Sept 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Sept 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Aug 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Aug 2019 — NON-FINAL ACTION E-MAILED
- 26 Aug 2019 — NON-FINAL ACTION WRITTEN